InsidersTradesSigma
Track the 마크로젠 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 마크로젠 has published 127 reports. Market capitalisation: €123.2bn. The latest transaction was filed on 25 June 2026 (Other). Among the most active insiders: 김창훈. All data is free.
127
Insider Decl.
n/a
Thresholds
n/a
21 ops.
Buy Volume
n/a
11 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,974 of 29,052 companies
34.0
score / 100
Value35
Quality33
FCF yld-10.0%
Earn yld1.5%
EV/EBITDA12.0x
ROE·
Gross mgn36%
Net mgn1.0%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 June 2026
Declarations127 total
25 of 127 declarations
About 마크로젠
마크로젠 is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on genomic and biotechnology services.